Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Author index

Page Path
HOME > Browse > Author index
Search
Ji Hyun Kim  (Kim JH) 4 Articles
Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
Ji Hyun Kim
Diabetes Metab J. 2015;39(4):304-306.   Published online August 17, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.4.304
  • 3,212 View
  • 41 Download
  • 3 Web of Science
  • 4 Crossref
PDFPubReader   

Citations

Citations to this article as recorded by  
  • Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials.gov Analysis
    Omar Hegazi, Samer Alalalmeh, Moyad Shahwan, Ammar Jairoun, Mansour Alourfi, Ghfran Bokhari, Abdullah Alkhattabi, Saeed Alsharif, Mohannad Aljehani, Abdulmalik Alsabban, Mohammad Almtrafi, Ysear Zakri, Abdullah AlMahmoud, Khalid Alghamdi, Ahmed Ashour, Na
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 545.     CrossRef
  • Combined treatment with a gastric inhibitory polypeptide receptor antagonist and a peptidyl peptidase-4 inhibitor improves metabolic abnormalities in diabetic mice
    Fei Yang, Shan Dang, Hongjun LV, Bingyin Shi
    Journal of International Medical Research.2021; 49(1): 030006052098566.     CrossRef
  • Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study
    Rahim Mohammad Naimi, Mark Krogh Hvistendahl, Lise Margrete Thomassen, Hanna Johnsen, Charlotte Bayer Christiansen, Jens Juul Holst, Bolette Hartmann, Palle Bekker Jeppesen
    BMJ Open Gastroenterology.2021; 8(1): e000604.     CrossRef
  • Hyperglucagonemia in an animal model of insulin- deficient diabetes: what therapy can improve it?
    Fabrizio Barbetti, Carlo Colombo, Leena Haataja, Corentin Cras-Méneur, Sergio Bernardini, Peter Arvan
    Clinical Diabetes and Endocrinology.2016;[Epub]     CrossRef
Severe Hypoglycemia Is a Serious Complication and Becoming an Economic Burden in Diabetes
Won Chul Ha, Su Jin Oh, Ji Hyun Kim, Jung Min Lee, Sang Ah Chang, Tae Seo Sohn, Hyun Shik Son
Diabetes Metab J. 2012;36(4):280-284.   Published online August 20, 2012
DOI: https://doi.org/10.4093/dmj.2012.36.4.280
  • 4,375 View
  • 33 Download
  • 36 Crossref
AbstractAbstract PDFPubReader   
Background

The prevalence of hypoglycemia is increasing due to the growing incidence of diabetes and the latest strict guidelines for glycated hemoglobin (HbA1c) levels under 7%. This study examined the clinical characteristics, causal factors, and medical costs of severely hypoglycemic patients in an emergency room (ER) of Uijeongbu St. Mary's Hospital.

Methods

The study consisted of a retrospective analysis of the characteristics, risk factors, and medical costs of 320 severely hypoglycemic patients with diabetes who presented to an ER of Uijeongbu St. Mary's Hospital from January 1, 2006 to December 31, 2009.

Results

Most hypoglycemic patients (87.5%, 280/320) were over 60 years old with a mean age of 69.5±10.9 years and a mean HbA1c level of 6.95±1.46%. Mean serum glucose as noted in the ER was 37.9±34.5 mg/dL. Renal function was decreased, serum creatinine was 2.0±2.1 mg/dL and estimated glomerular filtration rate (eGFR) was 48.0±33.6 mL/min/1.73 m2. In addition, hypoglycemic patients typically were taking sulfonylureas or insulin and a variety of other medications, and had a long history of diabetes.

Conclusion

Severe hypoglycemia is frequent in older diabetic patients, subjects with low HbA1c levels, and nephropathic patients. Therefore, personalized attention is warranted, especially in long-term diabetics with multiple comorbidities who may not have been properly educated or may need re-education for hypoglycemia.

Citations

Citations to this article as recorded by  
  • The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review
    Samuel J Westall, Ram Prakash Narayanan, Simon Watmough, Greg Irving, Niall Furlong, Sid McNulty, Sumudu Bujawansa, Kevin Hardy
    Clinical Medicine.2022; : clinmed.2021-0764.     CrossRef
  • Analysis of recurrent hypoglycemic events
    Chenchen Ma, Yongming Qu, Haoda Fu
    Journal of Biopharmaceutical Statistics.2021; 31(1): 5.     CrossRef
  • ROLE OF OCTREOTIDE IN MANAGEMENT OF SULPHONYLUREA - INDUCED REFRACTORY HYPOGLYCEMIA : A CASE REPORT
    Akshay Kothari, Kiran Shah
    INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2021; : 3.     CrossRef
  • Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
    João P. Ferreira, Francisco Araújo, Jorge Dores, Lèlita Santos, Estevão Pape, Mónica Reis, Árcia Chipepo, Edite Nascimento, Ana Baptista, Vanessa Pires, Carlos Marques, Adriana S. Lages, João Conceição, Pedro A. Laires, João Pelicano-Romano, Sílvia Alão
    Diabetes Therapy.2020; 11(10): 2237.     CrossRef
  • The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals
    Xiaomeng Yue, Jiuhong Wu, Zhen Ruan, Michael L. Wolden, Lanting Li, Yong Lin
    Value in Health Regional Issues.2020; 21: 17.     CrossRef
  • A closer look at the 2019 Beers criteria
    Rishabh Sharma, Malika Arora, Ravinder Garg, Parveen Bansal
    Drugs & Therapy Perspectives.2020; 36(3): 116.     CrossRef
  • Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
    Jee Hee Yoo, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2020; 44(6): 828.     CrossRef
  • Comparison of clinical pharmacy specialists and usual care in outpatient management of hyperglycemia in Veterans Affairs medical centers
    Heather L Ourth, Kwan Hur, Anthony P Morreale, Francesca Cunningham, Bharat Thakkar, Sherrie Aspinall
    American Journal of Health-System Pharmacy.2019; 76(1): 26.     CrossRef
  • Cost‐effectiveness of the psycho‐educational blended (group and online) intervention HypoAware compared with usual care for people with Type 1 and insulin‐treated Type 2 diabetes with problematic hypoglycaemia: analyses of a cluster‐randomized controlled
    M. de Wit, S. M. P. A. Rondags, M. W. van Tulder, F. J. Snoek, J. E. Bosmans
    Diabetic Medicine.2018; 35(2): 214.     CrossRef
  • Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arterioles
    Michael J. Tanner, Jingli Wang, Rong Ying, Tisha B. Suboc, Mobin Malik, Allison Couillard, Amberly Branum, Venkata Puppala, Michael E. Widlansky
    American Journal of Physiology-Heart and Circulatory Physiology.2017; 312(3): H515.     CrossRef
  • Hazardous factors besides infection in hypoglycemia
    Yu-Jang Su, Yen-Chun Lai, Chia-Jung Liao
    Biomedical Reports.2017; 6(4): 480.     CrossRef
  • Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea
    Gyuri Kim, Yong-ho Lee, Mi Hye Han, Eui-Kyung Lee, Chong Hwa Kim, Hyuk Sang Kwon, In Kyung Jeong, Eun Seok Kang, Dae Jung Kim, Massimo Pietropaolo
    PLOS ONE.2016; 11(3): e0151282.     CrossRef
  • Costs associated with emergency care and hospitalization for severe hypoglycemia
    G. Veronese, G. Marchesini, G. Forlani, S. Saragoni, L. Degli Esposti, E. Centis, A. Fabbri
    Nutrition, Metabolism and Cardiovascular Diseases.2016; 26(4): 345.     CrossRef
  • Risk of hospitalization for hypoglycemia among older Korean people with diabetes mellitus
    Hyun Min Kim, Jong-Mi Seong, Jaetaek Kim
    Medicine.2016; 95(42): e5016.     CrossRef
  • Risk factors of severe hypoglycemia requiring medical assistance and neurological sequelae in patients with diabetes
    Ja Young Jeon, Se Ran Kim, Hae Jin Kim, Dae Jung Kim, Kwan-Woo Lee, Jung-Dong Lee, Seung Jin Han
    Medicine.2016; 95(47): e5365.     CrossRef
  • Effectiveness of HypoAware, a Brief Partly Web-Based Psychoeducational Intervention for Adults With Type 1 and Insulin-Treated Type 2 Diabetes and Problematic Hypoglycemia: A Cluster Randomized Controlled Trial
    Stefanie M.P.A. Rondags, Maartje de Wit, Jos W. Twisk, Frank J. Snoek
    Diabetes Care.2016; 39(12): 2190.     CrossRef
  • The cost of managing severe hypoglycemic episodes in Type 2 diabetic patients
    Pedro Almeida Laires, João Conceição, Francisco Araújo, Jorge Dores, Catarina Silva, Larry Radican, Ana Nogueira
    Expert Review of Pharmacoeconomics & Outcomes Research.2016; 16(2): 315.     CrossRef
  • HypoAware: development and pilot study of a brief and partly web‐based psychoeducational group intervention for adults with Type 1 and insulin‐treated Type 2 diabetes and problematic hypoglycaemia
    S. M. P. A. Rondags, M. de Wit, F. J. Snoek
    Diabetic Medicine.2016; 33(2): 184.     CrossRef
  • Hypoglycemia and Health Costs
    Yong-ho Lee, Gyuri Kim, Eun Seok Kang
    The Journal of Korean Diabetes.2016; 17(1): 11.     CrossRef
  • Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes
    Jae-Seung Yun, Seung-Hyun Ko
    The Korean Journal of Internal Medicine.2015; 30(1): 6.     CrossRef
  • 1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
    Hannah Seok, Ji Hye Huh, Hyun Min Kim, Byung-Wan Lee, Eun Seok Kang, Hyun Chul Lee, Bong Soo Cha
    Diabetes & Metabolism Journal.2015; 39(2): 164.     CrossRef
  • Intensive Individualized Reinforcement Education Is Important for the Prevention of Hypoglycemia in Patients with Type 2 Diabetes
    Yun-Mi Yong, Kyung-Mi Shin, Kang-Min Lee, Jae-Young Cho, Sun-Hye Ko, Min-Hyang Yoon, Tae-Won Kim, Jong-Hyun Jeong, Yong-Moon Park, Seung-Hyun Ko, Yu-Bae Ahn
    Diabetes & Metabolism Journal.2015; 39(2): 154.     CrossRef
  • Hypoglycaemia in elderly patients with type 2 diabetes mellitus: a review of risk factors, consequences and prevention
    Badieh Jafari, Mary E. Britton
    Journal of Pharmacy Practice and Research.2015; 45(4): 459.     CrossRef
  • HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial
    Stefanie MPA Rondags, Maartje de Wit, Maurits W van Tulder, Michaela Diamant, Frank J. Snoek
    BMC Endocrine Disorders.2015;[Epub]     CrossRef
  • Hypoglycemia in Emergency Department
    Yu-Jang Su, Chia-Jung Liao
    Journal of Acute Disease.2015; 4(1): 59.     CrossRef
  • Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? Yes, They Continue to Serve Us Well!
    Martin J. Abrahamson
    Diabetes Care.2015; 38(1): 166.     CrossRef
  • Association Between Hypoglycemia and Fall-Related Events in Type 2 Diabetes Mellitus: Analysis of a U.S. Commercial Database
    Sumesh Kachroo, Hugh Kawabata, Susan Colilla, Lizheng Shi, Yingnan Zhao, Jayanti Mukherjee, Uchenna Iloeje, Vivian Fonseca
    Journal of Managed Care & Specialty Pharmacy.2015; 21(3): 243.     CrossRef
  • Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes
    Robert R. Henry, Julio Rosenstock, Douglas Logan, Thomas Alessi, Kenneth Luskey, Michelle A. Baron
    Journal of Diabetes and its Complications.2014; 28(3): 393.     CrossRef
  • Management of Diabetes Medications for Patients Undergoing Ambulatory Surgery
    Mary Ann Vann
    Anesthesiology Clinics.2014; 32(2): 329.     CrossRef
  • Principales factores asociados al coste de la diabetes mellitus tipo 2: revisión de la literatura
    Silvia Paz, Diego González Segura, Anna Raya Torres, Luis Lizan
    Avances en Diabetología.2014; 30(2): 34.     CrossRef
  • Incidence of hypoglycaemia associated with transient loss of consciousness. A retrospective cohort study
    A. Lagi, S. Cencetti, F. Lagi
    International Journal of Clinical Practice.2014; 68(8): 1029.     CrossRef
  • Hypoglycemia in Patients with Type 1 Diabetes: Epidemiology, Pathogenesis, and Prevention
    Omodele Awoniyi, Rabia Rehman, Samuel Dagogo-Jack
    Current Diabetes Reports.2013; 13(5): 669.     CrossRef
  • Diabetes: support for those at risk of malnutrition in the community
    Siobhan Hughes
    British Journal of Community Nursing.2012; 17(11): 529.     CrossRef
  • Diabetes patients at risk of malnutrition
    Siobhan Hughes
    Independent Nurse.2012;[Epub]     CrossRef
  • Type 2 diabetes: the evolution of a disease
    Harold E Lebovitz
    The British Journal of Diabetes & Vascular Disease.2012; 12(6): 290.     CrossRef
  • Severe Hypoglycemia in Patients with Diabetes
    Jae Seung Yun, Seung-Hyun Ko
    Diabetes & Metabolism Journal.2012; 36(4): 273.     CrossRef
Response: The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension (Diabetes Metab J 2011;35:236-42)
Ji Hyun Kim, Su Jin Oh, Jung Min Lee, Eun Gyoung Hong, Jae Myung Yu, Kyung Ah Han, Kyung Wan Min, Hyun Shik Son, Sang Ah Chang
Diabetes Metab J. 2011;35(4):429-430.   Published online August 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.4.429
  • 3,721 View
  • 27 Download
PDFPubReader   
The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension
Ji Hyun Kim, Su Jin Oh, Jung Min Lee, Eun Gyoung Hong, Jae Myung Yu, Kyung Ah Han, Kyung Wan Min, Hyun Shik Son, Sang Ah Chang
Diabetes Metab J. 2011;35(3):236-242.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.236
  • 28,879 View
  • 35 Download
  • 7 Crossref
AbstractAbstract PDFPubReader   
Background

Hypertension and type 2 diabetes mellitus are major risk factors for cardiovascular disease. This study analyzed the changes in central aortic waveforms and pulse wave velocity as well as related parameters after treatment with valsartan, an angiotensin II type 1 receptor blocker, in patients with type 2 diabetes and hypertension.

Methods

We used pulse wave analysis to measure central aortic waveform in a total of 98 subjects. In 47 of these patients, pulse wave velocity measurements were obtained before and after 12 weeks of treatment with valsartan.

Results

In the central aortic waveform analysis, the aortic pulse pressure and augmentation index were significantly decreased after valsartan treatment, as was the aortic pulse wave velocity. Factors contributing to the improvement in pulse wave velocity were the fasting blood glucose and haemoglobin A1c levels.

Conclusion

Short-term treatment with valsartan improves arterial stiffness in patients with type 2 diabetes and hypertension, and the glucose status at baseline was associated with this effect.

Citations

Citations to this article as recorded by  
  • Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial
    Rosalie A. Scholtes, Charlotte M. Mosterd, Anne C. Hesp, Mark M. Smits, Hiddo J. L. Heerspink, Daniël H. van Raalte
    Diabetes, Obesity and Metabolism.2023; 25(1): 198.     CrossRef
  • Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome
    Ami B Bhatt, J Stewart Buck, Jonah P Zuflacht, Jessica Milian, Samoneh Kadivar, Kimberlee Gauvreau, Michael N Singh, Mark A Creager
    Vascular Medicine.2015; 20(4): 317.     CrossRef
  • The impact of angiotensin receptor blockers on arterial stiffness: a meta-analysis
    Feng Peng, Hongming Pan, Bin Wang, Jinxiu Lin, Wenquan Niu
    Hypertension Research.2015; 38(9): 613.     CrossRef
  • Arterial stiffness in atherosclerotic renovascular hypertension
    Ljiljana Fodor, Vedran Premužić, Vanja Ivković, Dražen Perkov, Mario Laganović, Tajana Željković Vrkić, Živka Dika, Marijana Živko, Bojan Jelaković
    Journal of Hypertension.2014; 32(11): 2238.     CrossRef
  • Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients
    Vedran Savić, Barbara Eržen, Miodrag Janić, Mojca Lunder, Maja Boncelj, Karin Kanc, Andrej Janež, Mišo Šabovič
    Diabetes and Vascular Disease Research.2013; 10(5): 420.     CrossRef
  • The association between regional arterial stiffness and diabetic retinopathy in type 2 diabetes
    Won Jun Kim, Cheol-Young Park, Se Eun Park, Eun Jung Rhee, Won Young Lee, Ki Won Oh, Sung Woo Park, Sun Woo Kim, SuJeong Song
    Atherosclerosis.2012; 225(1): 237.     CrossRef
  • Letter: The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension (Diabetes Metab J 2011;35:236-42)
    Chul-Hee Kim
    Diabetes & Metabolism Journal.2011; 35(4): 427.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal